Treatment of pulmonary arterial hypertension: a step forward.
Sharma
Sat
S
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D019332:Endothelin-1 / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000959:Antihypertensive Agents; D019332:Endothelin-1; D010726:Phosphodiesterase Inhibitors; D013449:Sulfonamides; D011464:Epoprostenol; D000077300:Bosentan